Navigation Links
Poisonous Poisson
Date:12/5/2009

In contrast to the exhaustive research into venom produced by snakes and spiders, venomous fish have been neglected and remain something of a mystery. Now, a study of 158 catfish species, published in the open access journal BMC Evolutionary Biology, has catalogued the presence of venom glands and investigated their biological effects.

Jeremy Wright, from the University of Michigan, USA, carried out the investigation. He said, "I used histological and toxicological techniques to elucidate the diversity and distribution of venomous catfish. I found that at least 1250, and possibly over 1600 species of catfish may be venomous, a number far greater than any previous estimate of venomous catfish diversity"

Catfish venom glands are found in association with sharp, bony spines along the leading edge of the dorsal and pectoral fins, which can be locked into place when the catfish is threatened. When a spine enters a potential predator, the membrane surrounding the venom gland cells is torn, releasing venom into the wound. Wright describes how catfish venoms are neurotoxic and hemolytic, and are capable of producing a variety of effects such as severe pain, ischemia, muscle spasm and respiratory distress. However, as any one species examined produces no more than three distinct toxins in its venom, each species may not display all of these properties.

Wright's analyses indicate that there are at least two independent evolutionary origins of catfish venom glands. In addition, the toxic peptides show strong similarities with, and might be derived from, previously characterized toxins found in catfish epidermal secretions. "Further examination of the chemical composition of the venoms will provide valuable insight into the mechanisms and potential selective factors driving venom evolution in fishes", comments Wright.


'/>"/>

Contact: Graeme Baldwin
graeme.baldwin@biomedcentral.com
44-020-319-22165
BioMed Central
Source:Eurekalert  

Page: 1

Related biology news :

1. CU researcher engineers sorghum that grows in poisonous soils
2. Genetic technology reveals how poisonous mushrooms cook up toxins
3. Researchers develop new ultrasensitive assay to detect most poisonous substance known
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Poisonous Poisson
(Date:6/20/2016)... -- Securus Technologies, a leading provider of civil ... investigation, corrections and monitoring announced that after exhaustive ... the final acceptance by all three (3) Department ... (MAS) installed. Furthermore, Securus will have contracts for ... October, 2016. MAS distinguishes between legitimate wireless device ...
(Date:6/7/2016)... TORONTO , June 7, 2016  Syngrafii ... begun a business relationship that includes integrating Syngrafii,s ... pilot branch project. This collaboration will result in ... for the credit union, while maintaining existing document ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
(Date:6/1/2016)... 1, 2016 Favorable Government Initiatives ... and Criminal Identification to Boost Global Biometrics System Market ... TechSci Research report, " Global Biometrics Market By ... and Opportunities, 2011 - 2021", the global biometrics market ... on account of growing security concerns across various end ...
Breaking Biology News(10 mins):
(Date:11/30/2016)... SAN DIEGO and BEIJING ... Ltd., a leading commercial provider of genomic services and ... expertise, announced today that it has completed a USD ... China Merchants Bank Co., Ltd.,s CMB International Capital Management ... SDIC Innovation Investment Management Co., Ltd. ("SDIC Innovation") and ...
(Date:11/30/2016)... Mass. , Nov. 30, 2016   Merck ... that it has entered into a set of agreements ... services for Merck,s collection of genetic reagents such as ... with Evotec,s screening expertise offers an accelerated pathway to ... discovery starts with the identification of new targets, a ...
(Date:11/30/2016)... ... November 30, 2016 , ... ... development of a new orally administered treatment for Alzheimer’s disease (AD), today announced ... a Phase 2a clinical trial of T3D-959 in mild to moderate Alzheimer’s patients ...
(Date:11/30/2016)... ... November 30, 2016 , ... ProMIS Neurosciences (“ProMIS” or the ... diseases, today announced that all five of its validated monoclonal antibody (mAb) therapeutic ... toxic, prion-like forms of Amyloid beta (Aß) in vitro. , “We previously demonstrated ...
Breaking Biology Technology: